New medication reduced high triglyceride levels, improved cholesterol and liver health

Research Highlights:

  • In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three different…

Continue Reading